BRG1 Controls the Activity of the Retinoblastoma Protein via Regulation of p21^{CIP1/WAF1/SDI}

REFERENCES

• Aalfs, J. D., and Kingston R. E.. 2000. What does ‘chromatin remodeling’ mean? Trends Biochem. Sci. 25:548–555.
   Google Scholar
• Alcorta, D. A., Xiong Y., Phelps D., Hannon G., Beach D., and Barrett J. C.. 1996. Involvement of the cyclin-dependent kinase inhibitor p16 (INK4a) in replicative senescence of normal human fibroblasts. Proc. Natl. Acad. Sci. USA 93:13742–13747.
   PubMed Web of Science ®Google Scholar
• Berger, S. L. 2002. Histone modifications in transcriptional regulation. Curr. Opin. Genet. Dev. 12:142–148.
   PubMed Web of Science ®Google Scholar
• Betz, B. L., Strobeck M. W., Reisman D. N., Knudsen E. S., and Weissman B. E.. 2002. Re-expression of hSNF5/INI1/BAF47 in pediatric tumor cells leads to G(1) arrest associated with induction of p16ink4a and activation of RB. Oncogene 21:5193–5203.
   PubMed Web of Science ®Google Scholar
• Brehm, A., Miska E. A., McCance D. J., Reid J. L., Bannister A. J., and Kouzarides T.. 1998. Retinoblastoma protein recruits histone deacetylase to repress transcription. Nature 391:597–601.
   PubMed Web of Science ®Google Scholar
• Brown, J. P., Wei W., and Sedivy J. M.. 1997. Bypass of senescence after disruption of p21CIP1/WAF1 gene in normal diploid human fibroblasts. Science 277:831–834.
   PubMed Web of Science ®Google Scholar
• Buchkovich, K., Duffy L. A., and Harlow E.. 1989. The retinoblastoma protein is phosphorylated during specific phases of the cell cycle. Cell 58:1097–1105.
   PubMed Web of Science ®Google Scholar
• Bultman, S., Gebuhr T., Yee D., La Mantia C., Nicholson J., Gilliam A., Randazzo F., Metzger D., Chambon P., Crabtree G., and Magnuson T.. 2000. A Brg1 null mutation in the mouse reveals functional differences among mammalian SWI/SNF complexes. Mol. Cell 6:1287–1295.
   PubMed Web of Science ®Google Scholar
• Chen, P. L., Scully P., Shew J. Y., Wang J. Y., and Lee W. H.. 1989. Phosphorylation of the retinoblastoma gene product is modulated during the cell cycle and cellular differentiation. Cell 58:1193–1198.
   PubMed Web of Science ®Google Scholar
• Chen, X., Bargonetti J., and Prives C.. 1995. p53, through p21 (WAF1/CIP1), induces cyclin D1 synthesis. Cancer Res. 55:4257–4263.
   PubMed Web of Science ®Google Scholar
• Connell-Crowley, L., Harper J. W., and Goodrich D. W.. 1997. Cyclin D1/Cdk4 regulates retinoblastoma protein-mediated cell cycle arrest by site-specific phosphorylation. Mol. Biol. Cell 8:287–301.
   PubMed Web of Science ®Google Scholar
• DeCaprio, J. A., Furukawa Y., Ajchenbaum F., Griffin J. D., and Livingston D. M.. 1992. The retinoblastoma-susceptibility gene product becomes phosphorylated in multiple stages during cell cycle entry and progression. Proc. Natl. Acad. Sci. USA 89:1795–1798.
   PubMed Web of Science ®Google Scholar
• DeCaprio, J. A., Ludlow J. W., Lynch D., Furukawa Y., Griffin J., Piwnica-Worms H., Huang C. M., and Livingston D. M.. 1989. The product of the retinoblastoma susceptibility gene has properties of a cell cycle regulatory element. Cell 58:1085–1095.
   PubMed Web of Science ®Google Scholar
• DeCristofaro, M. F., Betz B. L., Wang W., and Weissman B. E.. 1999. Alteration of hSNF5/INI1/BAF47 detected in rhabdoid cell lines and primary rhabdomyosarcomas but not Wilms' tumors. Oncogene 18:7559–7565.
   PubMed Web of Science ®Google Scholar
• de la Serna, I. L., Roy K., Carlson K. A., and Imbalzano A. N.. 2001. MyoD can induce cell cycle arrest but not muscle differentiation in the presence of dominant negative SWI/SNF chromatin remodeling enzymes. J. Biol. Chem. 276:41486–41491.
   PubMedGoogle Scholar
• Dimri, G. P., Lee X., Basile G., Acosta M., Scott G., Roskelley C., Medrano E. E., Linskens M., Rubelj I., Pereira-Smith O., et al. 1995. A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc. Natl. Acad. Sci. USA 92:9363–9367.
   PubMed Web of Science ®Google Scholar
• Dunaief, J. L., Strober B. E., Guha S., Khavari P. A., Alin K., Luban J., Begemann M., Crabtree G. R., and Goff S. P.. 1994. The retinoblastoma protein and BRG1 form a complex and cooperate to induce cell cycle arrest. Cell 79:119–130.
   PubMed Web of Science ®Google Scholar
• Dyson, N. 1998. The regulation of E2F by pRB-family proteins. Genes Dev. 12:2245–2262.
   PubMed Web of Science ®Google Scholar
• Ewen, M. E., Sluss H. K., Sherr C. J., Matsushime H., Kato J., and Livingston D. M.. 1993. Functional interactions of the retinoblastoma protein with mammalian D-type cyclins. Cell 73:487–497.
   PubMed Web of Science ®Google Scholar
• Fang, L., Igarashi M., Leung J., Sugrue M. M., Lee S. W., and Aaronson S. A.. 1999. p21Waf1/Cip1/Sdi1 induces permanent growth arrest with markers of replicative senescence in human tumor cells lacking functional p53. Oncogene 18:2789–2797.
   PubMed Web of Science ®Google Scholar
• Fry, C. J., and Peterson C. L.. 2001. Chromatin remodeling enzymes: who's on first? Curr. Biol. 11:R185–R197.
   PubMed Web of Science ®Google Scholar
• Galaktionov, K., Chen X., and Beach D.. 1996. Cdc25 cell-cycle phosphatase as a target of c-myc. Nature 382:511–517.
   PubMed Web of Science ®Google Scholar
• Guidi, C. J., Sands A. T., Zambrowicz B. P., Turner T. K., Demers D. A., Webster W., Smith T. W., Imbalzano A. N., and Jones S. N.. 2001. Disruption of Ini1 leads to peri-implantation lethality and tumorigenesis in mice. Mol. Cell. Biol. 21:3598–3603.
   PubMed Web of Science ®Google Scholar
• Hassan, A. H., Neely K. E., Vignali M., Reese J. C., and Workman J. L.. 2001. Promoter targeting of chromatin-modifying complexes. Front. Biosci. 6:D1054–D1064.
   PubMedGoogle Scholar
• Hatakeyama, M., Brill J. A., Fink G. R., and Weinberg R. A.. 1994. Collaboration of G1 cyclins in the functional inactivation of the retinoblastoma protein. Genes Dev. 8:1759–1771.
   PubMed Web of Science ®Google Scholar
• Hinds, P. W., Mittnacht S., Dulic V., Arnold A., Reed S. I., and Weinberg R. A.. 1992. Regulation of retinoblastoma protein functions by ectopic expression of human cyclins. Cell 70:993–1006.
   PubMed Web of Science ®Google Scholar
• Hu, Q. J., Lees J. A., Buchkovich K. J., and Harlow E.. 1992. The retinoblastoma protein physically associates with the human cdc2 kinase. Mol. Cell. Biol. 12:971–980.
   PubMedGoogle Scholar
• Imbalzano, A. N., Kwon H., Green M. R., and Kingston R. E.. 1994. Facilitated binding of TATA-binding protein to nucleosomal DNA. Nature 370:481–485.
   PubMed Web of Science ®Google Scholar
• Jenuwein, T., and Allis C. D.. 2001. Translating the histone code. Science 293:1074–1080.
   PubMed Web of Science ®Google Scholar
• Kadam, S., McAlpine G. S., Phelan M. L., Kingston R. E., Jones K. A., and Emerson B. M.. 2000. Functional selectivity of recombinant mammalian SWI/SNF subunits. Genes Dev. 14:2441–2451.
   PubMed Web of Science ®Google Scholar
• Kato, J., Matsushime H., Hiebert S. W., Ewen M. E., and Sherr C. J.. 1993. Direct binding of cyclin D to the retinoblastoma gene product (pRb) and pRb phosphorylation by the cyclin D-dependent kinase CDK4. Genes Dev. 7:331–342.
   PubMed Web of Science ®Google Scholar
• Khavari, P. A., Peterson C. L., Tamkun J. W., Mendel D. B., and Crabtree G. R.. 1993. BRG1 contains a conserved domain of the SWI2/SNF2 family necessary for normal mitotic growth and transcription. Nature 366:170–174.
   PubMed Web of Science ®Google Scholar
• Kitagawa, M., Higashi H., Jung H. K., Suzuki-Takahashi I., Ikeda M., Tamai K., Kato J., Segawa K., Yoshida E., Nishimura S., and Taya Y.. 1996. The consensus motif for phosphorylation by cyclin D1-Cdk4 is different from that for phosphorylation by cyclin A/E-Cdk2. EMBO J. 15:7060–7069.
   PubMed Web of Science ®Google Scholar
• Klochendler-Yeivin, A., Fiette L., Barra J., Muchardt C., Babinet C., and Yaniv M.. 2000. The murine SNF5/INI1 chromatin remodeling factor is essential for embryonic development and tumor suppression. EMBO Rep. 1:500–506.
   PubMed Web of Science ®Google Scholar
• Klochendler-Yeivin, A., Muchardt C., and Yaniv M.. 2002. SWI/SNF chromatin remodeling and cancer. Curr. Opin. Genet. Dev. 12:73–79.
   PubMedGoogle Scholar
• Knudsen, E. S., and Wang J. Y.. 1996. Differential regulation of retinoblastoma protein function by specific Cdk phosphorylation sites. J. Biol. Chem. 271:8313–8320.
   PubMed Web of Science ®Google Scholar
• Lee, M. H., and Yang H. Y.. 2001. Negative regulators of cyclin-dependent kinases and their roles in cancers. Cell. Mol. Life Sci. 58:1907–1922.
   PubMed Web of Science ®Google Scholar
• Lin, A. W., Barradas M., Stone J. C., van Aelst L., Serrano M., and Lowe S. W.. 1998. Premature senescence involving p53 and p16 is activated in response to constitutive MEK/MAPK mitogenic signaling. Genes Dev. 12:3008–3019.
   PubMed Web of Science ®Google Scholar
• Lin, B. T., Gruenwald S., Morla A. O., Lee W. H., and Wang J. Y.. 1991. Retinoblastoma cancer suppressor gene product is a substrate of the cell cycle regulator cdc2 kinase. EMBO J. 10:857–864.
   PubMed Web of Science ®Google Scholar
• Liu, H., Kang H., Liu R., Chen X., and Zhao K.. 2002. Maximal induction of a subset of interferon target genes requires the chromatin-remodeling activity of the BAF complex. Mol. Cell. Biol. 22:6471–6479.
   PubMedGoogle Scholar
• Liu, R., Liu H., Chen X., Kirby M., Brown P. O., and Zhao K.. 2001. Regulation of CSF1 promoter by the SWI/SNF-like BAF complex. Cell 106:309–318.
   PubMed Web of Science ®Google Scholar
• Ludlow, J. W., Shon J., Pipas J. M., Livingston D. M., and DeCaprio J. A.. 1990. The retinoblastoma susceptibility gene product undergoes cell cycle-dependent dephosphorylation and binding to and release from SV40 large T. Cell 60:387–396.
   PubMed Web of Science ®Google Scholar
• Luo, R. X., Postigo A. A., and Dean D. C.. 1998. Rb interacts with histone deacetylase to repress transcription. Cell 92:463–473.
   PubMed Web of Science ®Google Scholar
• Magnaghi-Jaulin, L., Groisman R., Naguibneva I., Robin P., Lorain S., Le Villain J. P., Troalen F., Trouche D., and Harel-Bellan A.. 1998. Retinoblastoma protein represses transcription by recruiting a histone deacetylase. Nature 391:601–605.
   PubMed Web of Science ®Google Scholar
• Mittnacht, S. 1998. Control of pRB phosphorylation. Curr. Opin. Genet. Dev. 8:21–27.
   PubMed Web of Science ®Google Scholar
• Muchardt, C., and Yaniv M.. 1999. ATP-dependent chromatin remodelling: SWI/SNF and Co. are on the job. J. Mol. Biol. 293:187–198.
   PubMed Web of Science ®Google Scholar
• Nevins, J. R. 1998. Toward an understanding of the functional complexity of the E2F and retinoblastoma families. Cell Growth Differ. 9:585–593.
   PubMedGoogle Scholar
• Peterson, C. L., and Workman J. L.. 2000. Promoter targeting and chromatin remodeling by the SWI/SNF complex. Curr. Opin. Genet. Dev. 10:187–192.
   PubMed Web of Science ®Google Scholar
• Roberts, C. W., Galusha S. A., McMenamin M. E., Fletcher C. D., and Orkin S. H.. 2000. Haploinsufficiency of Snf5 (integrase interactor 1) predisposes to malignant rhabdoid tumors in mice. Proc. Natl. Acad. Sci. USA 97:13796–13800.
   PubMed Web of Science ®Google Scholar
• Ross, J. F., Liu X., and Dynlacht B. D.. 1999. Mechanism of transcriptional repression of E2F by the retinoblastoma tumor suppressor protein. Mol. Cell 3:195–205.
   PubMedGoogle Scholar
• Sager, R. 1991. Senescence as a mode of tumor suppression. Environ. Health Perspect. 93:59–62.
   PubMed Web of Science ®Google Scholar
• Serrano, M., Lin A. W., McCurrach M. E., Beach D., and Lowe S. W.. 1997. Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell 88:593–602.
   PubMed Web of Science ®Google Scholar
• Sevenet, N., Lellouch-Tubiana A., Schofield D., Hoang-Xuan K., Gessler M., Birnbaum D., Jeanpierre C., Jouvet A., and Delattre O.. 1999. Spectrum of hSNF5/INI1 somatic mutations in human cancer and genotype-phenotype correlations. Hum. Mol. Genet. 8:2359–2368.
   PubMed Web of Science ®Google Scholar
• Shanahan, F., Seghezzi W., Parry D., Mahony D., and Lees E.. 1999. Cyclin E associates with BAF155 and BRG1, components of the mammalian SWI-SNF complex, and alters the ability of BRG1 to induce growth arrest. Mol. Cell. Biol. 19:1460–1469.
   PubMed Web of Science ®Google Scholar
• Sherr, C., and McCormick F.. 2002. The RB and p53 pathways in cancer. Cancer Cell 2:103–112.
   PubMed Web of Science ®Google Scholar
• Staehling-Hampton, K., Ciampa P. J., Brook A., and Dyson N.. 1999. A genetic screen for modifiers of E2F in Drosophila melanogaster. Genetics 153:275–287.
   PubMed Web of Science ®Google Scholar
• Strobeck, M. W., Fribourg A. F., Puga A., and Knudsen E. S.. 2000. Restoration of retinoblastoma mediated signaling to Cdk2 results in cell cycle arrest. Oncogene 19:1857–1867.
   PubMed Web of Science ®Google Scholar
• Strobeck, M. W., Knudsen K. E., Fribourg A. F., DeCristofaro M. F., Weissman B. E., Imbalzano A. N., and Knudsen E. S.. 2000. BRG-1 is required for RB-mediated cell cycle arrest. Proc. Natl. Acad. Sci. USA 97:7748–7753.
   PubMed Web of Science ®Google Scholar
• Strober, B. E., Dunaief J. L., Guha, and Goff S. P.. 1996. Functional interactions between the hBRM/hBRG1 transcriptional activators and the pRB family of proteins. Mol. Cell. Biol. 16:1576–1583.
   PubMed Web of Science ®Google Scholar
• Sudarsanam, P., and Winston F.. 2000. The Swi/Snf family nucleosome-remodeling complexes and transcriptional control. Trends Genet. 16:345–351.
   PubMed Web of Science ®Google Scholar
• Sui, G., Soohoo C., Affar el B., Gay F., Shi Y., and Forrester W. C.. 2002. A DNA vector-based RNAi technology to suppress gene expression in mammalian cells. Proc. Natl. Acad. Sci. USA 99:5515–5520.
   PubMed Web of Science ®Google Scholar
• Templeton, D. J., Park S. H., Lanier L., and Weinberg R. A.. 1991. Nonfunctional mutants of the retinoblastoma protein are characterized by defects in phosphorylation, viral oncoprotein association, and nuclear tethering. Proc. Natl. Acad. Sci. USA 88:3033–3037.
   PubMed Web of Science ®Google Scholar
• Trouche, D., Le Chalony C., Muchardt C., Yaniv M., and Kouzarides T.. 1997. RB and hbrm cooperate to repress the activation functions of E2F1. Proc. Natl. Acad. Sci. USA 94:11268–11273.
   PubMed Web of Science ®Google Scholar
• Varga-Weisz, P. 2001. ATP-dependent chromatin remodeling factors: nucleosome shufflers with many missions. Oncogene 20:3076–3085.
   PubMed Web of Science ®Google Scholar
• Versteege, I., Sevenet N., Lange J., Rousseau-Merck M. F., Ambros P., Handgretinger R., Aurias A., and Delattre O.. 1998. Truncating mutations of hSNF5/INI1 in aggressive paediatric cancer. Nature 394:203–206.
   PubMed Web of Science ®Google Scholar
• Wang, W., Cote J., Xue Y., Zhou S., Khavari P. A., Biggar S. R., Muchardt C., Kalpana G. V., Goff S. P., Yaniv M., Workman J. L., and Crabtree G. R.. 1996. Purification and biochemical heterogeneity of the mammalian SWI-SNF complex. EMBO J. 15:5370–5382.
   PubMed Web of Science ®Google Scholar
• Wang, Y., Blandino G., and Givol D.. 1999. Induced p21waf expression in H1299 cell line promotes cell senescence and protects against cytotoxic effect of radiation and doxorubicin. Oncogene 18:2643–2649.
   PubMed Web of Science ®Google Scholar
• Weinberg, R. A. 1995. The retinoblastoma protein and cell cycle control. Cell 81:323–330.
   PubMed Web of Science ®Google Scholar
• Wu, J., and Grunstein M.. 2000. 25 years after the nucleosome model: chromatin modifications. Trends Biochem. Sci. 25:619–623.
   PubMed Web of Science ®Google Scholar
• Xu, H. J., Zhou Y., Ji W., Perng G. S., Kruzelock R., Kong C. T., Bast R. C., Mills G. B., Li J., and Hu S. X.. 1997. Reexpression of the retinoblastoma protein in tumor cells induces senescence and telomerase inhibition. Oncogene 15:2589–2596.
   PubMedGoogle Scholar
• Zhang, H. S., Gavin M., Dahiya A., Postigo A. A., Ma D., Luo R. X., Harbour J. W., and Dean D. C.. 2000. Exit from G1 and S phase of the cell cycle is regulated by repressor complexes containing HDAC-Rb-hSWI/SNF and Rb-hSWI/SNF. Cell 101:79–89.
   PubMed Web of Science ®Google Scholar
• Zhang, Z. K., Davies K. P., Allen J., Zhu L., Pestell R. G., Zagzag D., and Kalpana G. V.. 2002. Cell cycle arrest and repression of cyclin D1 transcription by INI1/hSNF5. Mol. Cell. Biol. 22:5975–5988.
   PubMed Web of Science ®Google Scholar
• Zhu, J., Woods D., McMahon M., and Bishop J. M.. 1998. Senescence of human fibroblasts induced by oncogenic Raf. Genes Dev. 12:2997–3007.
   PubMed Web of Science ®Google Scholar
• Zhu, L., Enders G., Lees J. A., Beijersbergen R. L., Bernards R., and Harlow E.. 1995. The pRB-related protein p107 contains two growth suppression domains: independent interactions with E2F and cyclin/cdk complexes. EMBO J. 14:1904–1913.
   PubMed Web of Science ®Google Scholar